These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14976227)

  • 1. Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo.
    Kawabata A; Kanke T; Yonezawa D; Ishiki T; Saka M; Kabeya M; Sekiguchi F; Kubo S; Kuroda R; Iwaki M; Katsura K; Plevin R
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1098-107. PubMed ID: 14976227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
    Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R
    Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist.
    McGuire JJ; Saifeddine M; Triggle CR; Sun K; Hollenberg MD
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1124-31. PubMed ID: 14976230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice.
    Kawabata A; Oono Y; Yonezawa D; Hiramatsu K; Inoi N; Sekiguchi F; Honjo M; Hirofuchi M; Kanke T; Ishiwata H
    Br J Pharmacol; 2005 Jan; 144(2):212-9. PubMed ID: 15655521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery.
    Matsumoto T; Ishida K; Taguchi K; Kobayashi T; Kamata K
    Peptides; 2009 Sep; 30(9):1729-34. PubMed ID: 19540892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepta and octapeptide agonists of protease-activated receptor 2.
    Devlin MG; Pfeiffer B; Flanagan B; Beyer RL; Cocks TM; Fairlie DP
    J Pept Sci; 2007 Dec; 13(12):856-61. PubMed ID: 17890655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands.
    Al-Ani B; Saifeddine M; Kawabata A; Renaux B; Mokashi S; Hollenberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):753-60. PubMed ID: 10411588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-2 peptides activate neurokinin-1 receptors in the mouse isolated trachea.
    Abey HT; Fairlie DP; Moffatt JD; Balzary RW; Cocks TM
    J Pharmacol Exp Ther; 2006 May; 317(2):598-605. PubMed ID: 16434565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor-2 (PAR-2)-related peptides induce tear secretion in rats: involvement of PAR-2 and non-PAR-2 mechanisms.
    Nishikawa H; Kawai K; Tanaka M; Ohtani H; Tanaka S; Kitagawa C; Nishida M; Abe T; Araki H; Kawabata A
    J Pharmacol Exp Ther; 2005 Jan; 312(1):324-31. PubMed ID: 15331653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinase-activated receptor-2 activating peptides: distinct canine coronary artery receptor systems.
    Saifeddine M; Seymour ML; Xiao YP; Compton SJ; Houle S; Ramachandran R; MacNaughton WK; Simonet S; Vayssettes-Courchay C; Verbeuren TJ; Hollenberg MD
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3279-89. PubMed ID: 17766477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2: binding and visualization.
    Hollenberg MD; Renaux B; Hyun E; Houle S; Vergnolle N; Saifeddine M; Ramachandran R
    J Pharmacol Exp Ther; 2008 Aug; 326(2):453-62. PubMed ID: 18477767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel agonists and antagonists for human protease activated receptor 2.
    Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
    J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of PAR-2 elicits NO-dependent and CGRP-independent dilation of the dural artery.
    Bhatt DK; Ploug KB; Ramachandran R; Olesen J; Gupta S
    Headache; 2010 Jun; 50(6):1017-30. PubMed ID: 20487037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery.
    Kawabata A; Kubo S; Nakaya Y; Ishiki T; Kuroda R; Sekiguchi F; Kawao N; Nishikawa H
    Cardiovasc Res; 2004 Mar; 61(4):683-92. PubMed ID: 14985065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro.
    Tognetto M; D'Andrea MR; Trevisani M; Guerrini R; Salvadori S; Spisani L; Daniele C; Andrade-Gordon P; Geppetti P; Harrison S
    Br J Pharmacol; 2003 May; 139(1):21-7. PubMed ID: 12746219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A refined agonist pharmacophore for protease activated receptor 2.
    Barry GD; Suen JY; Low HB; Pfeiffer B; Flanagan B; Halili M; Le GT; Fairlie DP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5552-7. PubMed ID: 17765542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo.
    Flynn AN; Tillu DV; Asiedu MN; Hoffman J; Vagner J; Price TJ; Boitano S
    J Biol Chem; 2011 May; 286(21):19076-88. PubMed ID: 21467041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder.
    Kirkland JG; Cottrell GS; Bunnett NW; Corvera CU
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G335-46. PubMed ID: 17431214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.